MEN1 and pancreatic neuroendocrine tumor: In addition, our results suggest that pasireotide may inhibit the development of pancreatic NETs in Men1+/− mice, thereby suggesting that it may also have a chemopreventative role in the treatment of MEN1-associated NETs.